Galecto Inc. is a biotechnology company focused on developing innovative therapies for fibrotic diseases and cancer. By leveraging its expertise in glycoscience, the company aims to create small molecule drugs that target specific pathological processes associated with these conditions. Galecto's research emphasizes the importance of the extracellular matrix in disease progression, and its pipeline includes candidates that seek to address critical unmet medical needs. The company's commitment to advancing scientific knowledge is coupled with a goal of improving patient outcomes through novel treatment options. Read More
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs. Here's a look at four stocks flashing strong momentum signals.
The session on Thursday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
On Tuesday, major U.S. indices closed lower, with the Dow Jones Industrial Average slipping 0.2% to 46,602.98, the S&P 500 falling nearly 0.4% to 6,714.59.
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their outstanding shares is at $5.6 million.
